The All of Us Research Program at the National Institutes of Health (NIH) has made significant progress since its national launch three years ago, building and providing unprecedented access to […]
“We take [compliance with ClinicalTrials.gov] requirements seriously,” says Miah Jung, PharmD, a pharmacologist with the U.S. Food and Drug Administration (FDA). While the FDA “hopes for voluntary compliance,” the agency […]
Clinical trials published in high-profile medical journals rarely report on income or other key sociodemographic characteristics of study participants, according to a new study that suggests these gaps may create […]
The moral argument is self-evident and powerful, but improving diversity in the clinical trial patient population and workforce is also the right thing to do from a scientific perspective, says […]
“Whatever we could do to make it easier for patients, we tried to do,” Patrick Floody, senior director of global study strategy and optimization at Regeneron, told attendees of the […]